Search results
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 2 hours agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
Why Things Could Get Worse for Pfizer Stock Before They Get Better
Motley Fool via Yahoo Finance· 2 days agoBut investors will need to be patient. The company's transition will take time Pfizer is facing some...
Is Pfizer the Best Dividend Stock for You?
Motley Fool via Yahoo Finance· 6 days agoAs a result, share prices have fallen and the stock trades near its lowest level in years. The falling share price has pushed the stock's dividend...pain...
Should You Pick Moderna Stock At $150 After 25% Gains In A Month?
Forbes· 9 hours agoModerna has a couple of factors to back its strong run. Firstly, the U.S. FDA recently approved...
California State Teachers Retirement System Increases Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 4 days agoCalifornia State Teachers Retirement System grew its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 1.5% during the fourth quarter, according to its most recent 13F filing ...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 4 days ago*Stock Advisor returns as of May 28, 2024 Cory Renauer has no position in any of the stocks...
Chutes & Ladders—Sanofi research head Frank Nestle says au revoir
FierceBiotech· 2 hours agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...
The Push to Get More People Into Long COVID Studies
Medscape· 3 days agoWhen Ezra Spier was diagnosed with long COVID in late 2022, his main symptom, postexertional malaise, caused fatigue so severe that it forced him to quit...
Retirement Roadblocks: 7 Stocks to Avoid as You Near the Finish Line
InvestorPlace· 4 days agoAs you approach retirement, it’s crucial to carefully consider your investment portfolio and make...
Blue-Chip Blunders: 7 Stocks to Sell as Management Missteps Mount
InvestorPlace· 5 days agoWhile macro-related issues are a factor, it’s company-specific issues that play a more significant...